Company · CIK 1709941

# BioAge Labs, Inc.

| CIK | [1709941](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001709941) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | BIOA (Nasdaq) |
| First annual or quarterly report | 2024-11-07 |

## Offerings

 4 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-294568 | Shelf Effective | 2026-03-24 | 2026-03-24 | 1 |
| 333-290688 | Shelf Effective | 2025-10-02 | 2026-01-22 | 3 |
| 333-290690 | Shelf Dormant | 2025-10-02 | 2025-10-02 | 1 |
| 333-281901 | IPO Final prospectus | 2024-09-03 | 2024-09-26 | 5 |

## Filings

 11

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-03-24 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1709941/000119312526121862/0001193125-26-121862-index.htm) Shelf registered | 333-294568 | 0001193125-26-121862 |
| 2026-01-22 | [424B5](https://www.sec.gov/Archives/edgar/data/1709941/000119312526019530/0001193125-26-019530-index.htm) Shelf takedown | 333-290688 | 0001193125-26-019530 |
| 2026-01-20 | [424B5](https://www.sec.gov/Archives/edgar/data/1709941/000119312526016537/0001193125-26-016537-index.htm) Shelf takedown | 333-290688 | 0001193125-26-016537 |
| 2025-10-02 | [S-3](https://www.sec.gov/Archives/edgar/data/1709941/000119312525228452/0001193125-25-228452-index.htm) Shelf registered | 333-290690 | 0001193125-25-228452 |
| 2025-10-02 | [S-3](https://www.sec.gov/Archives/edgar/data/1709941/000119312525228414/0001193125-25-228414-index.htm) Shelf registered | 333-290688 | 0001193125-25-228414 |
| 2024-09-26 | [424B4](https://www.sec.gov/Archives/edgar/data/1709941/000119312524226927/0001193125-24-226927-index.htm) Final prospectus | 333-281901 | 0001193125-24-226927 |
| 2024-09-25 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1709941/999999999524002965/9999999995-24-002965-index.htm) Declared effective | 333-281901 | 9999999995-24-002965 |
| 2024-09-25 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1709941/000119312524225155/0001193125-24-225155-index.htm) Amendment | 333-281901 | 0001193125-24-225155 |
| 2024-09-18 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1709941/000119312524221367/0001193125-24-221367-index.htm) Amendment | 333-281901 | 0001193125-24-221367 |
| 2024-09-03 | [S-1](https://www.sec.gov/Archives/edgar/data/1709941/000119312524212046/0001193125-24-212046-index.htm) Registration filed | 333-281901 | 0001193125-24-212046 |
| 2024-05-31 | [DRS](https://www.sec.gov/Archives/edgar/data/1709941/000095012324006073/0000950123-24-006073-index.htm) Draft made public | 377-07253 | 0000950123-24-006073 |

[All filings of this company](https://equitycapital.markets/filings?cik=1709941) · [CSV](https://equitycapital.markets/filings.csv?cik=1709941)

---
Source page: https://equitycapital.markets/company/1709941 · Data: U.S. SEC EDGAR · CC BY 4.0